Literature DB >> 7016185

The stability of liposomes in vitro to pH, bile salts and pancreatic lipase.

R N Rowland, J F Woodley.   

Abstract

If liposomes are to be effective as carriers for the oral administration of insulin they must be able to withstand passage through the stomach and small intestine. Multilamellar liposomes, some identical in composition to those used in reported in vivo studies on the uptake of orally administered insulin, were tested in vitro for their stability in the presence of bile salts, pancreatic lipase, and variations in pH. While low or high pH had little effect on most liposomes, 10 mM bile salts caused the release of over 80% of entrapped marker from all liposomes tested except those composed of distearoyl phosphatidylcholine/cholesterol and those composed of dipalmitoyl phosphatidylethanolamine/cholesterol/dicetylphosphate. However, the latter were unstable at low pH. The distearoyl phosphatidylcholine/cholesterol liposomes were also resistant to pancreatic lipase, and therefore may be suitable for use in the oral administration of therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7016185     DOI: 10.1016/0005-2760(80)90131-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.

Authors:  K E Anderson; L A Eliot; B R Stevenson; J A Rogers
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  Liposome-Encapsulated Bacteriophages for Enhanced Oral Phage Therapy against Salmonella spp.

Authors:  Joan Colom; Mary Cano-Sarabia; Jennifer Otero; Pilar Cortés; Daniel Maspoch; Montserrat Llagostera
Journal:  Appl Environ Microbiol       Date:  2015-05-08       Impact factor: 4.792

3.  Effect of Entrapped Markers on the in situ Jejunal Uptake from Liposomal Systems.

Authors:  D L Schwinke; M G Ganesan; N D Weiner
Journal:  Pharm Res       Date:  1984-11       Impact factor: 4.200

4.  Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingivalis fimbriae administered orally.

Authors:  T Ogawa; H Shimauchi; S Hamada
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

Review 5.  miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?

Authors:  A K M Nawshad Hossian; Gerardo G Mackenzie; George Mattheolabakis
Journal:  Nanomedicine (Lond)       Date:  2019-11-18       Impact factor: 5.307

6.  Cholate-induced disruption of calcitonin-loaded liposomes: formation of trypsin-resistant lipid-calcitonin-cholate complexes.

Authors:  A Ariën; N Toulmé-Henry; B Dupuy
Journal:  Pharm Res       Date:  1995-09       Impact factor: 4.200

Review 7.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.

Authors:  Samuel K Lai; Ying-Ying Wang; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2008-12-13       Impact factor: 15.470

8.  Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration.

Authors:  Y Aramaki; H Tomizawa; T Hara; K Yachi; H Kikuchi; S Tsuchiya
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

9.  Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes.

Authors:  Varaporn Buraphacheep Junyaprasert; Veerawat Teeranachaideekul; Tasaneeya Supaperm
Journal:  AAPS PharmSciTech       Date:  2008-07-18       Impact factor: 3.246

10.  Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.

Authors:  Zerrin Sezgin-Bayindir; Mustafa Naim Antep; Nilufer Yuksel
Journal:  AAPS PharmSciTech       Date:  2014-09-10       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.